Thermo Fisher Scientific Inc. (TMO)

501,59 -4,07 (-0,80%) Börsenschluss: 04:00PM EDT

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
https://www.thermofisher.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 130.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Marc N. Casper	Chairman, Pres & CEO	8,01M	52,48M	1968
Mr. Stephen Williamson	Sr. VP & CFO	2,95M	12,14M	1967
Mr. Michel Lagarde	Exec. VP & COO	3,3M	15,18M	1975
Mr. Michael A. Boxer Esq.	Sr. VP & Gen. Counsel	1,76M	2,9M	1962
Mr. Gianluca Pettiti	Exec. VP	2,11M	1,82M	1979
Mr. Joseph R. Holmes	VP & Chief Accounting Officer	N/A	N/A	1980
Mr. Ryan J. Snyder	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Dr. Karen E. Nelson Ph.D.	Chief Scientific Officer & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Rafael Tejada	VP of Investor Relations	N/A	N/A	N/A
Ms. Sandy B. Pound	VP & Chief Communications Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.s ISS Governance QualityScore, Stand 1. September 2023, lautet 6. Die grundlegenden Scores sind Audit: 4, Vorstand: 8, Shareholderrechte: 4, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.